Specialty Pharmacy

E-Consults Increase Access to Specialty Care, Reduce Need for Face-to-Face Appointments

Boston (06/26/16) – According to research presented today at AcademyHealth’s Annual Research Meeting, use by physicians of electronic consultations (e-consults) increases access to specialists’ care for patients who often have the hardest time getting a specialist, including the uninsured, underinsured and those living in rural areas. E-consults leverage electronic health …

Read More »

Alzheimer’s Genetics Point to New Research Direction

A University of Adelaide analysis of genetic mutations which cause early-onset Alzheimer’s disease suggests a new focus for research into the causes of the disease. Previous research has revolved around the idea that accumulation in the brain of a small, sticky protein fragment — amyloid beta — causes Alzheimer’s disease. …

Read More »

OptiMed Specialty Pharmacy Extends its Reach of Patient-Centered Care

Kalamazoo, Michigan – OptiMed Specialty Pharmacy, a privately-held specialty pharmacy headquartered in Kalamazoo, Michigan, announced today the acquisition of the Specialty Pharmacy Business line of Advanced Therapeutics, a leading health care company in California. OptiMed Specialty Pharmacy aims to help patients, providers and stakeholders navigate the intricacies of specialty medication …

Read More »

Premier Acquires Lincare Holdings’ Specialty Pharmacy Business

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has agreed to acquire the national specialty pharmacy business of Lincare Holdings Inc., headquartered in Clearwater, Fla. The $75 million acquisition includes Acro Pharmaceutical Services LLC and Community Pharmacy Services, LLC. Premier expects to fund the transaction with available …

Read More »

CVS Study Shows that Home Infusion Care Improves Patient Outcomes and QOL While Reducing Costs

WOONSOCKET, R.I., May 4, 2016 /PRNewswire/ — A new study by the CVS Health Research Institute found that home infusion care is safe, clinically effective and improves quality of life while reducing health care costs when compared to infusion care delivered in a hospital or clinic. The findings underscore the …

Read More »

FDA Approves Oral Suspension Formulation of Eisai’s Fycompa

WOODCLIFF LAKE, N.J., May 2, 2016 /PRNewswire/ — Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved FYCOMPA® (perampanel) CIII Oral Suspension as adjunctive therapy for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures, and primary generalized tonic-clonic (PGTC) seizures in …

Read More »

FDA Approves Acadia’s Nuplazid for Parkinson’s-Related Psychosis

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease. Hallucinations or delusions can occur in as many as 50 percent of patients with Parkinson’s disease at some time during …

Read More »

Diplomat to Acquire Oncology-Focused TNH Advanced Specialty Pharmacy

FLINT, Mich., April 28, 2016 /PRNewswire/ — Click here for supplemental information regarding the transaction. Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation’s largest independent specialty pharmacy, announced today that it has signed a definitive agreement to acquire Valley Campus Pharmacy, Inc., doing business as TNH Advanced Specialty Pharmacy (“TNH”), a leading …

Read More »